Atsushi Isoda

Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan

Takashi Tokunaga, Kazuyuki Shimada, Kazuhito Yamamoto et al. · Blood · 2012 · 135 citations · Full text

Expression of L‐type amino acid transporter 1 (<scp>LAT</scp>1) as a prognostic and therapeutic indicator in multiple myeloma

Atsushi Isoda, Kyoichi Kaira, Masanori Iwashina et al. · Cancer Science · 2014 · 59 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pathology +17

Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma

Ikue Okamura, Hisao Imai, Keita Mori et al. · International Journal of Hematology · 2014 · 30 citations

Lymphoid Neoplasia, Rituximab Monotherapy, Medicine +7

Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome

Atsushi Isoda, Atsushi Sakurai, Yoshiyuki Ogawa et al. · International Journal of Hematology · 2009 · 25 citations

Hematological Malignancy, Myelodysplastic Syndrome, Autoimmune Disease +14

18F-FAMT in patients with multiple myeloma: clinical utility compared to 18F-FDG

Atsushi Isoda, Tetsuya Higuchi, Sachiko Nakano et al. · Annals of Nuclear Medicine · 2012 · 21 citations

Hematological Malignancy, Clinical Utility, Medicine +9